IHS Chemical Week

Regions :: Western Europe :: Denmark

Novo Nordisk invests over $100 million in new purification plant in Denmark

7:28 AM MDT | March 17, 2014 | Deepti Ramesh

Health-care company Novo Nordisk (Bagsvaerd, Denmark) says it is increasing its drug development capacity by investing 550 million Danish kroner ($102 million) in a new facility at Bagsvaerd. The purification plant will expand the company’s capacity to produce active pharmaceutical ingredients for a growing number of diabetes drugs under development, Novo Nordisk says. The pilot plant will be fully operational by late 2016 and will be run by CMC Supply—chemistry, manufacturing, and control supply—a unit within Novo Nordisk R&D. CMC Supply...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa